Follow this preprint
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD
Fatima Amanat, Mahima Thapa, Tinting Lei, Shaza M. Sayed Ahmed, Daniel C. Adelsberg, Juan Manuel Carreno, Shirin Strohmeier, Aaron J. Schmitz, Sarah Zafar, View ORCID ProfileJulian Q Zhou, Willemijn Rijnink, Hala Alshammary, Nicholas Borcherding, Ana Gonzalez Reiche, Komal Srivastava, View ORCID ProfileEmilia Mia Sordillo, View ORCID ProfileHarm van Bakel, The Personalized Virology Initiative, Jackson S. Turner, Goran Bajic, Viviana Simon, View ORCID ProfileAli H. Ellebedy, Florian Krammer
doi: https://doi.org/10.1101/2021.03.07.21253098
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Fatima Amanat
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Mahima Thapa
3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA
Tinting Lei
3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA
Shaza M. Sayed Ahmed
3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA
Daniel C. Adelsberg
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Juan Manuel Carreno
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Shirin Strohmeier
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Aaron J. Schmitz
3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA
Sarah Zafar
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Julian Q Zhou
4AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada
Willemijn Rijnink
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Hala Alshammary
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Nicholas Borcherding
3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA
Ana Gonzalez Reiche
5Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Komal Srivastava
Emilia Mia Sordillo
6Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Harm van Bakel
5Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
7Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Jackson S. Turner
3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA
Goran Bajic
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Viviana Simon
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
8Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
9The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Ali H. Ellebedy
3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA
10Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, MO 63110, USA
11Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, Saint Louis, MO 63110, USA
Florian Krammer
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Picked up by 1 news outlets
Blogged by 2
Tweeted by 1441
On 1 videos
72 readers on Mendeley
Posted May 01, 2021.
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD
Fatima Amanat, Mahima Thapa, Tinting Lei, Shaza M. Sayed Ahmed, Daniel C. Adelsberg, Juan Manuel Carreno, Shirin Strohmeier, Aaron J. Schmitz, Sarah Zafar, Julian Q Zhou, Willemijn Rijnink, Hala Alshammary, Nicholas Borcherding, Ana Gonzalez Reiche, Komal Srivastava, Emilia Mia Sordillo, Harm van Bakel, The Personalized Virology Initiative, Jackson S. Turner, Goran Bajic, Viviana Simon, Ali H. Ellebedy, Florian Krammer
medRxiv 2021.03.07.21253098; doi: https://doi.org/10.1101/2021.03.07.21253098
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (721)
- Anesthesia (214)
- Cardiovascular Medicine (3047)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12964)
- Forensic Medicine (12)
- Gastroenterology (849)
- Genetic and Genomic Medicine (4779)
- Geriatric Medicine (441)
- Health Economics (747)
- Health Informatics (3031)
- Health Policy (1097)
- Hematology (405)
- HIV/AIDS (953)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (492)
- Neurology (4552)
- Nursing (243)
- Nutrition (673)
- Oncology (2366)
- Ophthalmology (667)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (297)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1232)
- Primary Care Research (516)
- Public and Global Health (7140)
- Radiology and Imaging (1588)
- Respiratory Medicine (941)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (506)
- Toxicology (63)
- Transplantation (218)
- Urology (188)